Italia markets closed

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqCM - NasdaqCM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
0,2142-0,0073 (-3,30%)
Alla chiusura: 04:00PM EDT
0,2151 +0,00 (+0,42%)
Dopo ore: 07:59PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente0,2215
Aperto0,2317
Denaro0,2151 x 800
Lettera0,2200 x 2200
Min-Max giorno0,2100 - 0,2317
Intervallo di 52 settimane0,2080 - 1,3200
Volume1.316.016
Media Volume866.450
Capitalizzazione26,832M
Beta (5 anni mensile)1,93
Rapporto PE (ttm)N/D
EPS (ttm)-0,3120
Prossima data utili10 nov 2022 - 14 nov 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A1,98
  • GlobeNewswire

    Akari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officer

    Industry veteran brings extensive experience in the development and commercialization of advanced biological therapies, including in the field of complement (C5)NEW YORK and LONDON, March 02, 2022 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement (C5) and/or leukotriene (LBT4) systems are implicated, today announced the appointment of Rachelle

  • GlobeNewswire

    uniQure Announces the Appointment of Rachelle Jacques to its Board of Directors

    Biotech Executive Brings Extensive Experience Developing Advanced Therapies and Regenerative Medicines Rachelle Jacques Newly elected uniQure board member, Rachelle Jacques LEXINGTON, Mass. and AMSTERDAM, Oct. 21, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the appointment of Rachelle Jacques to its Board of Directors. Ms. Jacques, who will serve on the Board’s Audi